Effect of testosterone on oxidative stress and cell damage induced by 3-nitropropionic acid in striatum of ovariectomized rats

Life Sciences

Volumn 80, Issue 13, 2007, Pages 1221-1227

  Túnez, Isaac ^a   Feijóo, Montserrat ^a   Collado, Juan A ^b   Medina, Francisco J ^a   Peña, José ^a   Muñoz, María del C ^a   Jimena, Ignacio ^a   Franco, Francisco ^a   Rueda, Ignacio ^a   Muntané, Jordi ^b   Montilla, Pedro ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

3 Nitropropionic acid; Cell damage; Huntington's disease; Oxidative stress; Testosterone

Indexed keywords

3 NITROPROPIONIC ACID; CASPASE 3; LACTATE DEHYDROGENASE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DAMAGE; CELL LOSS; CONTROLLED STUDY; CORPUS STRIATUM; DEGENERATIVE DISEASE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GONADECTOMY; HUNTINGTON CHOREA; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; PATHOGENESIS; RAT;

ANDROGENS; ANIMALS; CELL DEATH; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DRUG ANTAGONISM; FEMALE; HUNTINGTON DISEASE; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; L-LACTATE DEHYDROGENASE; LIPID PEROXIDATION; NEUROTOXINS; NITRO COMPOUNDS; OVARIECTOMY; OXIDATIVE STRESS; PROPIONIC ACIDS; RATS; RATS, WISTAR; TESTOSTERONE;

RATTUS;

EID: 33847253354     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.12.013     Document Type: Article

References (50)

1. Aebi H. Catalase in vitro. Methods in Enzymology 105 (1984) 121-126
2. Ahlbom E., Prins G.S., and Ceccatelli S. Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism. Brain Research 892 (2001) 255-262
3. Anderson K.E., and Marder L.S. An overview of psychiatric symptoms in Huntington's disease. Current Psychiatry Reports 3 (2001) 379-388
4. Azcoitia I., Sierra A., Veiga S., Honda S.I., Harada N., and García-Segura L.M. Brain aromatase is neuroprotective. Journal of Neurobiology 47 (2001) 318-329
5. Bizat N., Hermal J.M., Boyer F., Jacquard C., Créminon C., Ouary S., Escartin C., Hantraye P., Krayewski S., and Crouillet E. Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease. Journal of Neuroscience 23 (2003) 5020-5030
6. Bonelli R.M., and Hoffmann P. A review of the treatment options for Huntington's disease. Expert Opinion on Pharmacotherapy 5 (2004) 767-776
7. Borlongan C.V., Koutouzis T.K., Freeman T.B., Cahill D.W., and Sanseberg P.R. Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington's disease. Brain Research 697 (1995) 254-257
8. Borlongan C.V., Nishino H., and Sanberg P.R. Systemic, but not intraparenchymal, administration of 3-nitropropionic acid mimics the neuropathology of Huntington's disease. Neuroscience Research 28 (1997) 185-189
9. Brouillet M., Hantraye P., Ferrante R.J., Dolan R., Leroy-Willig A., and Kowall N.W. Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proceedings of the National Academy of Sciences of the United State of America 92 (1995) 7105-7109
10. Calderón Guzmán D., Barragán Mejía G., Espitia Vázquez I., Hernández García E., Santamaría del Ángel D., and Juárez Olguín H. Effect of testosterone and steroids homologues on indolamines and lipid peroxidation in rat brain. The Journal of Steroid Biochemistry and Molecular Biology 94 (2005) 369-373
11. Chisu V., Manca P., Lepore G., Gadau S., Zedda M., and Farina V. Testosterone induces neuroprotection from oxidative stress. Effects on catalase activity and 3-nitro-l-tyrosine incorporation into alpha-tubulin in a mouse neuroblastoma cell. Archives Intaliennes de Biologie 144 (2006) 63-73
12. Flohé L., and Gunzler W.A. Assays of glutathione peroxidase. Methods in Enzymology 105 (1984) 114-121
13. García-Segura L.M., Chowen J.A., Parducz A., and Naftolin F. Gonadal hormones as promoters of structural synaptic plasticity: cellular mechanisms. Progress in Neurobiology 4 (1994) 279-307
14. Hammond J., Le Q., Goodyer C., Gelfand M., Trifiro M., and LeBlanc A. Testosterone-mediated neuroprotection through the androgen receptor in human primary neurons. Journal of Neurochemistry 77 (2001) 1319-1326
15. Hiltunen M., Livonen S., and Soininen H. Aromatase enzyme and Alzheimer's disease. Minerva Endocrinologica 31 (2006) 61-73
16. Hogervost E., Williams J., Budge M., Barnetson L., Combrinck M., and Smith A.D. Serum total testosterone is lower in men with Alzheimer's disease. Neuroendocrinology Letters 22 (2001) 163-168
17. Huppenbauer C., Tanzer L., Don Carlos L., and Jones K.J. Gonadal steroid attenuation of developing hamster facial motoneurons loss by axotomy: equal effect of testosterone, dihydrotestosterone, and 17-β estradiol. The Journal of Neuroscience 25 (2005) 4004-4013
18. Kujawa K.A., Kinderman N.B., and Jones K.J. Testosterone-induced acceleration of recovery from facial paralysis following crush axotomy of the facial nerve in male hamsters. Experimental Neurology 105 (1989) 80-85
19. Kume-Kick J., Ferris D.C., Russo-Menna I., and Rice M.E. Enhanced oxidative stress in female rat brain after gonadectomy. Brain Research 738 (1996) 8-14
20. La Fontaine M.A., Geddes J.W., Banks A., and Butterfield D.A. 3-Nitropropionic acid induced in vivo protein oxidation in striatal and cortical synaptosomes: insights into Huntington's disease. Brain Research 858 (2000) 356-362
21. La Fontaine M.A., Geddes J.W., Banks A., and Butterfield D.A. Effect of exogenous and endogenous antioxidants on 3-nitropropionic acid-induced in vivo oxidative stress and striatal lesions: insights into Huntington's disease. Journal of Neurochemistry 75 (2000) 1709-1715
22. La Fontaine M.A., Geddes J.W., and Butterfield D.A. 3-Nitropropionic acid-induced changes in bilayer fluidity in synaptosomal membranes: implications for Huntington's disease. Neurochemistry Research 27 (2002) 507-511
23. Leranth C., Petnehazy O., and MacLusky N.J. Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats. Journal of Neuroscience 23 (2003) 1588-1592
24. Levine R.L., Garland D., Olivier C.N., Amici A., Climent I., Lenz A.G., Ahn B.W., Shaltiel S., and Stadtmen E.R. Determination of carbonyl content in oxidatively modified proteins. Methods in Enzymology 186 (1990) 464-478
25. Lewis C., McEwen B.S., and Frankfurt M. Estrogen-induction of dendritic spines in ventromedial hypothalamus and hippocampus: effect of neonatal blockade and adult GDX. Developmental Brain Research 87 (1995) 91-95
26. Markianos M., Panas M., Kalfakis N., and Vassilopoulos D. Plasma testosterone in male patients with Huntington's disease: relations to severity of illness and dementia. Annals of Neurology 57 (2005) 520-525
27. Martín J.B., and Gusella J.F. Huntington's disease: pathogenesis and management. New England Journal of Medicine 315 (1986) 1267-1276
28. Militello A., Vitello G., Lunetta C., Toscano A., Maiorana G., Piccoli T., and La Bella V. The serum level of free testosterone is reduced in amyotrophic lateral sclerosis. Journal of the Neurological Sciences 195 (2002) 67-70
29. i increase and cell damage in cultured rat cerebral endothelial cells. Brain Research 956 (2002) 116-125
30. Montilla P., Túnez I., Muñoz M.C., Salcedo M., Feijóo M., Muñoz-Castañeda J.R., and Bujalance I. Effect of glucocorticoids on 3-nitropropionic acid-induced oxidative stress in synaptosomes. European Journal of Pharmacology 488 (2004) 19-25
31. Nishino H., Makajima K., Kumazaki M., Fukuda A., Muramatsu K., Deshpande S.B., Inubushi T., Morikawa S., Borlongan C.V., and Sanberg P.R. Estrogen protects against while testosterone exacerbates vulnerability of the lateral striatal artery to chemical hypoxia by 3-nitropropionic acid. Neuroscience Research 30 (1998) 303-312
32. Nishino H., Hida H., Kumazaki M., Shimano Y., Nakajima K., Shimizu H., Iowa T., and Baba H. The striatum is the most vulnerable region in the brain to mitochondrial energy compromise: a hypothesis to explain its specific vulnerability. Journal of Neurotrauma 17 (2000) 251-260
33. Nordeen E.J., Nordeen K.W., Sengelaub D.R., and Arnold A.P. Androgens prevent normally occurring cell death in a sexually dimorphic spinal nucleus. Science 229 (1985) 671-673
34. Okun M.S., McDonald M.W.M., and DeLong M.R. Refractory nonmotor symptoms in male patients with Parkinson's disease due to testosterone deficiency: a common unrecognized comorbidity. Archives of Neurology 59 (2002) 807-811
35. Okun M.S., DeLong M.R., Hanfelt J., Gearing M., and Levey A. Plasma testosterone levels in Alzheimer and Parkinson's diseases. Neurology 62 (2004) 411-413
36. Pang Z., Bondada V., Sengoku T., Siman R., and Geddes J.W. Calpain facilitates the neuron death induced by 3-nitropropionic acid and contributes to the necrotic morphology. Journal of Neuropathology and Experimental Neurology 62 (2003) 633-643
37. Poumeau-Delille G. Techniques biologiques en endocrinologie experimentale chez rat (1953), Masson & Cie, Paris
38. Raber J., Bongers G., LeFevour A., Buttini M., and Mucke L. Androgens protect against apolipoprotein E4-induced cognitive deficits. The Journal of Neuroscience 22 (2002) 5204-5209
39. Ramsden M., Shin T.M., and Pike J. Androgens modulate neuronal vulnerability to kainate lesion. Neuroscience 122 (2003) 573-578
40. Rubinow D.R., and Schmidt P.J. Androgens, brain, and behaviour. American Journal of Psychiatry 153 (1996) 974-984
41. Springer J.E., Azbill R.D., and Carlson S.L. A rapid and sensitive assay for measuring mitochondrial metabolic activity in isolated neural tissue. Brain Research Protocols 2 (1997) 259-263
42. Strack A., Duffy C.F., Malvey M., and Arriaga E.A. Individual mitochondrion characterization: a comparison of classical assays to capillary electrophoresis with laser-induced fluorescence detection. Analytical Biochemistry 294 (2001) 141-147
43. Strauss K.A., and Morton D.H. Type I glutaric aciduria, Part 2: a model of acute striatal necrosis. American Journal of Medical Genetics Part C 121C (2003) 53-70
44. Taffs R., and Sitkovsky M. In vitro assays for mouse B and T lymphocyte function. In: Coligan J.E., Kruisbeek A.M., Margulies D.H., Shevach E.M., and Strober W. (Eds). Current Protocols in Immunology (1991), Greene Publishing and Wiley Interscience, New York 1-18
45. Túnez I., Montilla P., Muñoz M.C., and Drucker-Colín R. Effect of nicotine on 3-nitropropionic acid-induced oxidative stress in synaptosomes. European Journal of Pharmacology 504 (2004) 169-175
46. Túnez I., Montilla P., Muñoz M.C., Feijóo M., and Salcedo M. Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease. Journal of Pineal Research 3 (2004) 252-256
47. Túnez I., Muñoz M.C., and Montilla P. Treatment with dehydroepiandrosterone prevents oxidative stress induced by 3-nitropropionic acid in synaptosomes. Pharmacology 74 (2005) 113-118
48. Túnez I., Collado J.A., Medina F.J., Peña J., Muñoz M.C., Jimena I., Franco F., Rueda I., Feijóo M., Muntané J., and Montilla P. 17 β-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington's disease in ovariectomized rats. Neurochemistry International 48 (2006) 367-373
49. Veiga S., García-Segura L.M., and Azcoitia I. Neuroprotection by the steroids pregnenolone and dehydroepiandrosterone is mediated by enzyme aromatase. Journal of Neurobiology 56 (2003) 398-406
50. Vis J.C., de Boer-van Guisen R.T., Verbeek M.M., de Waal R.M., ten Donkelaar H.J., and Kremer B. 3-Nitropropionic acid induces cell death and mitochondrial dysfunction in rat corticostriatal slice cultures. Neuroscience Letters 329 (2002) 86-90